Creative Details

Quality Score: N/A

Creative Information

CID:1ad0a322-975e-405d-8b2a-b880f1948219
CRID:25_9q5eyxmc
Domain:ultomiris.com
Seat:TTD
Size:9544x9544
Bid:$3.05
Timestamp:10/31/2025, 2:23:22 AM
Declared IAB Categories:

    Analysis

    3 succeeded2 failed(60% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysisfailed10/31/2025, 2:23:23 AMN/A
    adomain_analysissuccess10/31/2025, 4:55:03 AM3.99s
    adomain_capturesuccess10/31/2025, 4:54:59 AM0.18s
    ad_renderfailed12/10/2025, 12:52:29 AMN/A
    brand_mappingsuccess10/31/2025, 2:23:23 AM0.09s

    Analysis Results

    Ad Format: native

    Brands: Ultomiris

    No analysis results available

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Native Ad

    Myasthenia Gravis: The Road to Individualized Treatment

    Raw Ad Markup

    {"assets":[{"id":5,"required":0,"title":{"text":"Myasthenia Gravis: The Road to Individualized Treatment"}},{"id":6,"required":0,"img":{"url":"https://ad.adsrvr.org/a0vvs99/7pgty93/9q5eyxmc_main_0_1200x627.jpg","w":1200,"h":627,"ext":{"type":3}}},{"id":8,"required":0,"data":{"value":"Learn more","ext":{"type":12}}},{"id":10,"required":0,"data":{"value":"Health Union","ext":{"type":1}}},{"id":11,"required":0,"data":{"value":"Find new perspectives on personalizing MG treatment and how to align your approach with what matters most to each patient.","ext":{"type":2}}}],"imptrackers":["https://wa2-bid.adsrvr.org/bid/feedback/kargo?t=1&iid=612f3e35-28c7-4433-bd9e-6d20493a5cd1&crid=9q5eyxmc&wp=3.0470173&aid=ba96a1b0-b47f-4c6f-aa07-e832c6f95c0c&wpc=USD&sfe=1b385ed1&puid=d52c1815-ab17-49e0-43f7-069c358b2406&bdc=137&tdid=ff419d15-e63c-4283-ac7e-9856b34e9005&uidd=FiYwOcC1rEevqAd_yT1vd5nzQgN7DtdV3rC4AIhPXpYPJBKv&pid=a0vvs99&ag=wahb0oi&adv=7pgty93&sig=1iVvg7_Bl0iuHPE2jK1KUcjkL4j-OEueJ27BvrYTSg9g.&bp=14&cf=9537130&fq=0&td_s=www.yahoo.com&rcats=y29&mste=&mfld=3&mssi=&mfsi=&uhow=56&agsa=&rgz=97701&svbttd=1&dt=PC&osf=Windows&os=Windows10&br=Chrome&rlangs=en&mlang=&svpid=8727&did=&rcxt=Other&lat=44.094400&lon=-121.286300&tmpc=2.0400000000000205&daid=&vp=0&osi=&osv=&bffi=41&testid=iavc1%20&npt=2&cc=1~KLUv_WNa1XJFZgB1CQCzEUTeQB5vAM8buGMN2PUMWH8F7lg0BBCxBPI8gTx2tH5vdoZ0CVkdDoS5E6MbG9M7BQoS-MJakULAylqRQgCKH4CKOWBnDrBjDrAyB0Bxhaz7B9C5wqP7BwxpB-R4E4CXAqwnoI0XAMUHgOQLkBfgmufP-oUvwBBRAoQsEiBmXOCWJr8Fid26-4V4bO0btqC0W0n8VpC_laPVQsVqgfJpYXqgBUlAEC1EAoJo5WmZ0e0nNYVPa4f33mel8VlWnwWlwZqsIA3WYKESILzPgHF_WIo8FhSPlcS7ebSAOXrCLPf_VLU-SKzvrnbgM9P7eZ6te2Fky4GJ22B_yEWBFRRIBocSXdEqcAqIxRfw1EUQM5YBOAf8pUwwGWvDf7AzNNXs_apPgOVMhGVO1goyBw..&dur=1~KLUv_WMFoCgkJgDtAgBzxBARRBBBBD6qC8hgSaP8skVJO3VFSFR2Pl1-qEwVQRFp2RnqR1OeaBao_aTUBcjV6sItFSlQIOGBF48CnNRNSNqpZlqVBvzKbLlwisvyeDNZqa8mT08I5IEie24.&durs=SqEOJ2&crrelr=&fpa=218&pcm=3&vc=12&said=a1c37678-97b0-4790-963e-3fe527ee4739&ict=WiFi&auct=1&us_privacy=1YNN&im=1&mc=cde5fd4a-b8ba-47ff-86ff-44329242a19b&idl=XY3007AFRQo3jSVh25S0oVJPFyRmp5V3NLvogiX5yRGRuOv9U&ev=dTQcG2RVqEtNJAgMyStBfY4ADekESRyp7e4o3tmil1A.&rsv=0.00000106427786031325&abr=6231e247-0ab8-4e8a-9ca9-8feed86cd3bd&tail=1"],"link":{"clicktrackers":[],"url":"https://insight.adsrvr.org/track/clk?imp=612f3e35-28c7-4433-bd9e-6d20493a5cd1&ag=wahb0oi&sfe=1b385ed1&sig=dS6_AhYgXrdNYMfLqpqOfzg_HEDVA6Luns9tIeHgE-M.&crid=9q5eyxmc&cf=9537130&fq=0&t=1&td_s=www.yahoo.com&rcats=y29&mste=&mfld=3&mssi=&mfsi=&sv=kargo&uhow=56&agsa=&wp=3.0470173&rgz=97701&dt=PC&osf=Windows&os=Windows10&br=Chrome&svpid=8727&rlangs=en&mlang=&did=&rcxt=Other&tmpc=2.0400000000000205&vrtd=&osi=&osv=&daid=&dnr=0&vpb=&crrelr=&npt=2&cc=1~KLUv_WNa1XJFZgB1CQCzEUTeQB5vAM8buGMN2PUMWH8F7lg0BBCxBPI8gTx2tH5vdoZ0CVkdDoS5E6MbG9M7BQoS-MJakULAylqRQgCKH4CKOWBnDrBjDrAyB0Bxhaz7B9C5wqP7BwxpB-R4E4CXAqwnoI0XAMUHgOQLkBfgmufP-oUvwBBRAoQsEiBmXOCWJr8Fid26-4V4bO0btqC0W0n8VpC_laPVQsVqgfJpYXqgBUlAEC1EAoJo5WmZ0e0nNYVPa4f33mel8VlWnwWlwZqsIA3WYKESILzPgHF_WIo8FhSPlcS7ebSAOXrCLPf_VLU-SKzvrnbgM9P7eZ6te2Fky4GJ22B_yEWBFRRIBocSXdEqcAqIxRfw1EUQM5YBOAf8pUwwGWvDf7AzNNXs_apPgOVMhGVO1goyBw..&dur=1~KLUv_WMFoCgkJgDtAgBzxBARRBBBBD6qC8hgSaP8skVJO3VFSFR2Pl1-qEwVQRFp2RnqR1OeaBao_aTUBcjV6sItFSlQIOGBF48CnNRNSNqpZlqVBvzKbLlwisvyeDNZqa8mT08I5IEie24.&durs=SqEOJ2&bdc=137&uidd=FiYwOcC1rEevqAd_yT1vd5nzQgN7DtdV3rC4AIhPXpYPJBKv&idl=XY3007AFRQo3jSVh25S0oVJPFyRmp5V3NLvogiX5yRGRuOv9U&testid=iavc1%20&fpa=218&pcm=3&ict=WiFi&said=a1c37678-97b0-4790-963e-3fe527ee4739&auct=1&us_privacy=1YNN&tail=1&r=https://myasthenia-gravis.com/hcp/myasthenia-gravis-the-road-to-individualized-treatment?utm_source=ttdnative&utm_medium=hcp-native&imp_id=612f3e35-28c7-4433-bd9e-6d20493a5cd1"},"native":{"assets":""}}

    Creatives